Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Guardant Health, Inc.(GH) | 3,393,312 | 2,805,677 | -587,635 | $509.10M | $500.42M | 8.42% | -$8.68M |
| BioMarin Pharmaceutical Inc.(BMRN) | 3,307,481 | 6,374,395 | +3,066,914 | $189.25M | $382.46M | 6.44% | +$193.21M |
| Immunovant, Inc.(IMVT) | 9,341,151 | 9,160,801 | -180,350 | $359.91M | $309.45M | 5.21% | -$50.46M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 3,666,768 | 3,806,768 | +140,000 | $230.79M | $299.25M | 5.04% | +$68.46M |
| Veradermics, Incorporated(MANE) | 2,000,000 | 1,900,000 | -100,000 | $245.88M | $230.34M | 3.88% | -$15.54M |
| Vera Therapeutics, Inc.CL A(VERA) | 4,000,000 | 7,000,000 | +3,000,000 | $171.64M | $226.03M | 3.80% | +$54.39M |
| Vaxcyte, Inc.(PCVX) | 4,300,000 | 3,513,069 | -786,931 | $249.96M | $199.89M | 3.36% | -$50.07M |
| Alkermes plcSHS(ALKS) | 4,000,000 | 4,500,000 | +500,000 | $209.58M | $182.34M | 3.07% | -$27.24M |
| Ocular Therapeutix, Inc.(OCUL) | 19,686,282 | 21,939,625 | +2,253,343 | $193.32M | $168.28M | 2.83% | -$25.04M |
| United Therapeutics Corporation(UTHR) | 123,616 | 300,040 | +176,424 | $66.98M | $162.59M | 2.74% | +$95.61M |
| Structure Therapeutics IncADS | 4,740,072 | 5,000,000 | +259,928 | $254.40M | $156.35M | 2.63% | -$98.05M |
| GRAIL, Inc.(GRAL) | 1,834,944 | 1,104,200 | -730,744 | $125.27M | $154.72M | 2.60% | +$29.45M |
| Insmed Incorporated(INSM) | 0 | 1,350,000 | +1,350,000 | $0 | $154.09M | 2.59% | +$154.09M |
| COMPASS Pathways plcADS(CMPS) | 12,161,496 | 12,161,496 | 0 | $172.09M | $151.29M | 2.55% | -$20.80M |
| Genmab A/SADS(GMAB) | 5,650,000 | 4,182,689 | -1,467,311 | $155.21M | $149.22M | 2.51% | -$5.99M |
| Axsome Therapeutics, Inc.(AXSM) | 700,000 | 800,000 | +100,000 | $171.34M | $147.51M | 2.48% | -$23.83M |
| Nurix Therapeutics, Inc.(NRIX) | 7,736,455 | 6,000,000 | -1,736,455 | $187.69M | $142.26M | 2.39% | -$45.43M |
| LB Pharmaceuticals Inc(LBRX) | 3,352,804 | 3,352,804 | 0 | $108.82M | $128.68M | 2.17% | +$19.87M |
| Tango Therapeutics, Inc.(TNGX) | 4,200,000 | 4,500,000 | +300,000 | $131.29M | $112.28M | 1.89% | -$19.02M |
| Maze Therapeutics, Inc.(MAZE) | 3,732,569 | 4,083,969 | +351,400 | $111.38M | $111.00M | 1.87% | -$377.6K |
| Hemab Therapeutics Hldgs Inc | 3,602,093 | 3,587,796 | -14,297 | $132.30M | $110.65M | 1.86% | -$21.66M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 6,999,025 | 8,105,290 | +1,106,265 | $136.27M | $94.83M | 1.60% | -$41.44M |
| Oruka Therapeutics, Inc.(ORKA) | 1,926,000 | 1,069,774 | -856,226 | $183.30M | $89.10M | 1.50% | -$94.20M |
| GeneDx Holdings Corp.CL A(WGS) | 700,000 | 1,200,000 | +500,000 | $48.05M | $86.76M | 1.46% | +$38.70M |
| Cogent Biosciences, Inc.(COGT) | 2,000,000 | 2,500,000 | +500,000 | $77.40M | $80.05M | 1.35% | +$2.65M |
| GH Research PLC(GHRS) | 3,333,334 | 3,333,334 | 0 | $89.60M | $78.27M | 1.32% | -$11.33M |
| Bicara Therapeutics Inc | 4,100,000 | 4,100,000 | 0 | $121.73M | $76.30M | 1.28% | -$45.43M |
| Latigo Biotherapeutics Inc | 0 | 4,408,322 | +4,408,322 | $0 | $73.62M | 1.24% | +$73.62M |
| Celldex Therapeutics, Inc.(CLDX) | 2,939,151 | 2,125,532 | -813,619 | $109.37M | $68.89M | 1.16% | -$40.48M |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 885,882 | +885,882 | $0 | $58.29M | 0.98% | +$58.29M |
| Avalo Therapeutics Inc | 3,610,000 | 3,610,000 | 0 | $66.71M | $55.34M | 0.93% | -$11.37M |
| Alumis Inc | 6,348,558 | 7,469,746 | +1,121,188 | $178.65M | $55.20M | 0.93% | -$123.45M |
| Altimmune Inc | 19,250,000 | 19,250,000 | 0 | $58.52M | $55.05M | 0.93% | -$3.46M |
| Attovia Therapeutics Inc | 0 | 3,207,138 | +3,207,138 | $0 | $54.97M | 0.93% | +$54.97M |
| Billiontoone IncCL A | 0 | 500,000 | +500,000 | $0 | $53.22M | 0.90% | +$53.22M |
| Aclaris Therapeutics Inc | 9,345,000 | 9,345,000 | 0 | $49.44M | $49.15M | 0.83% | -$280.4K |
| Cormedix Inc | 6,274,076 | 6,274,076 | 0 | $49.25M | $48.31M | 0.81% | -$941.1K |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 1,148,817 | +1,148,817 | $0 | $46.64M | 0.78% | +$46.64M |
| Verastem, Inc.(VSTM) | 5,740,850 | 5,740,850 | 0 | $21.93M | $46.21M | 0.78% | +$24.28M |
| Definium Therapeutics, Inc.(DFTX) | 2,750,000 | 1,000,000 | -1,750,000 | $129.36M | $38.06M | 0.64% | -$91.30M |
| Generate Biomedicines, Inc.(GENB) | 1,333,815 | 2,507,449 | +1,173,634 | $22.50M | $37.66M | 0.63% | +$15.16M |
| MBX Biosciences, Inc.(MBX) | 1,732,569 | 640,000 | -1,092,569 | $95.64M | $37.52M | 0.63% | -$58.12M |
| ANI Pharmaceuticals, Inc.(ANIP) | 0 | 500,000 | +500,000 | $0 | $36.33M | 0.61% | +$36.33M |
| Viridian Therapeutics, Inc.(VRDN) | 3,592,740 | 1,711,030 | -1,881,710 | $66.00M | $35.23M | 0.59% | -$30.77M |
| Harrow, Inc.(HROW) | 969,000 | 1,069,000 | +100,000 | $41.15M | $32.93M | 0.55% | -$8.23M |
| Obsidian Therapeutics Inc | 0 | 2,120,050 | +2,120,050 | $0 | $29.11M | 0.49% | +$29.11M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 2,491,939 | 2,491,939 | 0 | $37.23M | $28.71M | 0.48% | -$8.52M |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 200,000 | +200,000 | $0 | $28.37M | 0.48% | +$28.37M |
| Solid Biosciences Inc | 3,565,062 | 3,565,062 | 0 | $35.61M | $25.78M | 0.43% | -$9.84M |
| Shattuck Labs Inc | 3,706,734 | 3,706,734 | 0 | $25.72M | $25.28M | 0.43% | -$444.8K |
| Beam Therapeutics Inc.(BEAM) | 1,000,000 | 1,000,000 | 0 | $34.32M | $24.45M | 0.41% | -$9.87M |
| MannKind Corporation(MNKD) | 6,000,000 | 5,030,522 | -969,478 | $25.56M | $19.62M | 0.33% | -$5.94M |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 500,000 | +500,000 | $0 | $18.59M | 0.31% | +$18.59M |
| Olema Pharmaceuticals Inc | 1,500,000 | 2,109,951 | +609,951 | $18.77M | $18.23M | 0.31% | -$535.0K |
| Nektar Therapeutics(NKTR) | 300,000 | 300,000 | 0 | $20.94M | $18.16M | 0.31% | -$2.78M |
| Design Therapeutics Inc | 0 | 1,323,986 | +1,323,986 | $0 | $16.64M | 0.28% | +$16.64M |
| Century Therapeutics Inc | 9,462,645 | 9,462,645 | 0 | $23.18M | $16.18M | 0.27% | -$7.00M |
| Xencor, Inc.(XNCR) | 593,551 | 540,000 | -53,551 | $9.56M | $13.47M | 0.23% | +$3.92M |
| Maplight Therapeutics Inc | 0 | 1,318,101 | +1,318,101 | $0 | $13.43M | 0.23% | +$13.43M |
| Enanta Pharmaceuticals Inc | 1,444,167 | 1,000,000 | -444,167 | $21.06M | $13.18M | 0.22% | -$7.88M |
| X4 Pharmaceuticals Inc | 5,878,757 | 4,501,684 | -1,377,073 | $27.45M | $13.05M | 0.22% | -$14.40M |
| Kardigan Inc | 600,000 | 600,000 | 0 | $14.31M | $8.85M | 0.15% | -$5.46M |
| Promis Neurosciences Inc | 835,655 | 740,117 | -95,538 | $11.00M | $8.03M | 0.14% | -$2.97M |
| Entera Bio LtdSHS | 0 | 2,450,980 | +2,450,980 | $0 | $7.13M | 0.12% | +$7.13M |
| Rxsight Inc | 0 | 1,230,566 | +1,230,566 | $0 | $6.03M | 0.10% | +$6.03M |
| Rainier Acquisition CorpUNIT 08 24 2031 | 0 | 500,000 | +500,000 | $0 | $5.10M | 0.09% | +$5.10M |
| Jatt Iii Acquisition Corp | 0 | 450,000 | +450,000 | $0 | $4.96M | 0.08% | +$4.96M |
| Research Alliance Corp IvCL A | 0 | 400,000 | +400,000 | $0 | $4.63M | 0.08% | +$4.63M |
| Tcgx Acquisition CorpCL A | 0 | 300,000 | +300,000 | $0 | $3.75M | 0.06% | +$3.75M |
| Aligos Therapeutics Inc | 444,110 | 444,110 | 0 | $2.56M | $2.50M | 0.04% | -$62.2K |
| Context Therapeutics Inc | 7,419,355 | 7,419,355 | 0 | $4.11M | $2.23M | 0.04% | -$1.88M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 825,000 | 0 | -825,000 | $248.35M | $0 | — | -$248.35M |
| Ataibeckley Inc | 14,417,442 | 0 | -14,417,442 | $75.98M | $0 | — | -$75.98M |
| Cytokinetics, Incorporated(CYTK) | 700,000 | 0 | -700,000 | $59.63M | $0 | — | -$59.63M |
| Dyne Therapeutics, Inc.(DYN) | 1,500,000 | 0 | -1,500,000 | $33.31M | $0 | — | -$33.31M |
| Enliven Therapeutics Inc | 225,000 | 0 | -225,000 | $11.42M | $0 | — | -$11.42M |
| Immix Biopharma, Inc.(IMMX) | 2,775,000 | 0 | -2,775,000 | $28.61M | $0 | — | -$28.61M |
| Immunocore Holdings plcADS(IMCR) | 311,218 | 0 | -311,218 | $9.88M | $0 | — | -$9.88M |
| Inventiva S.A.ADS(IVA) | 800,000 | 0 | -800,000 | $3.02M | $0 | — | -$3.02M |
| Ionis Pharmaceuticals, Inc.(IONS) | 2,200,000 | 0 | -2,200,000 | $174.44M | $0 | — | -$174.44M |
| Kailera Therapeutics Inc | 700,000 | 0 | -700,000 | $15.42M | $0 | — | -$15.42M |
| Kura Oncology, Inc.(KURA) | 1,978,565 | 0 | -1,978,565 | $21.70M | $0 | — | -$21.70M |
| Nuvalent Inc | 1,783,322 | 0 | -1,783,322 | $220.24M | $0 | — | -$220.24M |
| Personalis, Inc.(PSNL) | 4,000,000 | 0 | -4,000,000 | $53.60M | $0 | — | -$53.60M |